Veronica Boley
Payments from drug & device makers
Across 435 payments — averaging $14.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$689
- Otsuka America Pharmaceutical, Inc.$378
- Alkermes, Inc.$294
- Indivior Inc.$284
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,094100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 142 | $1,373 |
| AbbVie | 89 | $1,313 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 59 | $689 |
| Otsuka America Pharmaceutical, Inc. | 20 | $378 |
| Alkermes, Inc. | 15 | $294 |
| Indivior Inc. | 13 | $284 |
| AstraZeneca | 12 | $233 |
| Braeburn Inc. | 11 | $215 |
| Axsome Therapeutics, Inc. | 6 | $139 |
| Lilly USA, LLC | 9 | $139 |
| Novo Nordisk | 9 | $137 |
| Ardelyx, Inc. | 6 | $127 |
| Vanda Pharmaceuticals Inc. | 6 | $120 |
| Amgen | 6 | $115 |
| Pfizer | 5 | $85 |
| Redhill Biopharma Inc. | 4 | $71 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $65 |
| Gilead | 3 | $59 |
| Dexcom, Inc. | 3 | $57 |
| Biodelivery Sciences International, Inc. | 4 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Nestle Healthcare Nutrition Inc. | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Medtronic | 1 | $21 |
| Novartis | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
How this compares
$6,099 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 24 | $55,410 |
| JardianceEmpagliflozin | 62 | $47,865 |
| MounjaroTirzepatide | 41 | $41,240 |
| OzempicSemaglutide | 33 | $31,109 |
| VraylarCariprazine Hcl | 17 | $23,614 |
| FarxigaDapagliflozin Propanediol | 38 | $22,837 |
| LinzessLinaclotide | 41 | $22,600 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $21,373 |
| TrulicityDulaglutide | 19 | $18,001 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 22 | $9,521 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,409 |
| EliquisApixaban | 13 | $8,409 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 60 | $7,867 |
| JanuviaSitagliptin Phosphate | 13 | $7,415 |
| TrulancePlecanatide | 13 | $7,128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor, Trulance | $1,373 | $62,53837 claims |
| Lilly USA, LLCMounjaro, Trulicity | $139 | $59,24060 claims |
| AbbVieVraylar, Linzess | $1,313 | $46,21458 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $233 | $44,21067 claims |
| Novo NordiskOzempic | $137 | $31,10933 claims |
| Indivior Inc.Suboxone | $284 | $9,52122 claims |
| PfizerEliquis | $85 | $8,40913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Gray
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.